SkinBioTherapeutics PLC's (LON:SBTX) Stuart Ashman talks to Proactive London about their wholly-owned subsidiary AxisBiotix Limited which is getting ready for their food supplement consumer study.
The study, which will accept around 200 applicants, the participants will be asked to take a powdered food supplement dissolved in a glass of water on a daily basis and the study will run for a total of 56 days (2 x 28-day blocks).
The supplements have been manufactured by Winclove and are currently being packaged ahead of shipment to the company in early February.
Ashman talks through in detail their drive for commercialisation, with talks already underway.